March 3, 2026Frontiers in Oncology2 citationsOpen Access
Pan-immune-inflammation value and prognostic nutritional index can predict the 2-year recurrence of triple-negative breast cancer patients after radical resection
Two-year recurrence rates can be effectively predicted using pan-immune-inflammation value and prognostic nutritional index in patients with triple-negative breast cancer after radical surgery.
The analysis showed that using these indicators could significantly aid clinicians in managing patient care and follow-up strategies.
Both PIV and PNI demonstrate a potential role as biomarkers for recurrence risk, combining immune inflammation and nutritional status for better outcomes.
These findings highlight the need for incorporating PIV and PNI into routine assessments for tailored treatment plans to improve patient prognosis.
Abstract
PIV and PNI can serve as effective indicators for predicting recurrence within 2 years after radical surgery in TNBC patients, providing a more scientific reference for clinicians.